Carlos Eduardo González-Matos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carlos Eduardo González-Matos has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Ermengol Vallès
Department of Cardiology, Hospital del Mar Medical Research Institute, Barcelona, Spain
3 shared publications - Benjamin Jacques Casteigt
Department of Cardiology, Hospital del Mar Medical Research Institute, Barcelona, Spain
2 shared publications - Jesús Jiménez-López
Electrophysiology Unit. Cardiovascular Division. Hospital del Mar. Passeig Maritim de la Barceloneta. Barcelona. Spain
2 shared publications - Andrea Di Marco
Department of Cardiology, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain; Bioheart Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, CIBER-CV, Madrid, Spain
1 shared publication - Antonella Battista
Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Via Amendola 2, Reggio Emilia 42122, Italy
1 shared publication - Axel Sarrias
Servicio de Cardiología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 4 October 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (10) , 501
Safety and Cost-Analysis of Same-Day Versus Next-Day Discharge Following Complex Ablation Procedures: A Single-Centre Observational Study
(1) Introduction and objectives: The most common practice after a complex ablation procedure (CAP) is next-day discharge (NDD) following an appropriate observation period. However, the use of same-day discharge (SDD) has increased substantially since the COVID-19 pandemic. We aimed to evaluate the safety and cost-analysis of an SDD strategy for patients undergoing CAP. (2) Methods: This was a single-centre, retrospective observational study of patients undergoing CAP between January 2021 and July 2024, with intracardiac echocardiography used in all procedures. (3) Results: A total of 250 CAPs were performed, with a complication rate of 20.4% in the initial cohort. Forty-five patients were excluded, mainly because of significant procedural complications or severe pre-ablation medical conditions. The final analysis included 205 patients: 70 in the SDD group and 135 in the NDD group. Multiple patient and procedural characteristics were evaluated and compared between the groups. Among patients included in the final analysis, the overall complication rate was low (8.8%), with no differences between groups (early minor complications, 5.4%: 8.6% vs. 3.7% for SDD vs. NDD, p = 0.191; late major complications, 0.5%: 0% vs. 0.7%, p = 1; late minor complications, 3.4%: 2.9% vs. 3.7%, p = 1). There were five deaths (2.4%), none of which were procedure related. The SDD policy for CAP during this period would have saved €479.84 ± €248.09 per patient. (4) Conclusions: An SDD strategy was feasible and cost-saving and seemed to not increase periprocedural complications compared with an NDD strategy.
- 4 October 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (10) , 501
Open AccessSafety and Cost-Analysis of Same-Day Versus Next-Day Discharge Following Complex Ablation Procedures: A Single-Centre Observational Study
(1) Introduction and objectives: The most common practice after a complex ablation procedure (CAP) is next-day discharge (NDD) following an appropriate observation period. However, the use of same-day discharge (SDD) has increased substantially since the COVID-19 pandemic. We aimed to evaluate the safety and cost-analysis of an SDD strategy for patients undergoing CAP. (2) Methods: This was a single-centre, retrospective observational study of patients undergoing CAP between January 2021 and July 2024, with intracardiac echocardiography used in all procedures. (3) Results: A total of 250 CAPs were performed, with a complication rate of 20.4% in the initial cohort. Forty-five patients were excluded, mainly because of significant procedural complications or severe pre-ablation medical conditions. The final analysis included 205 patients: 70 in the SDD group and 135 in the NDD group. Multiple patient and procedural characteristics were evaluated and compared between the groups. Among patients included in the final analysis, the overall complication rate was low (8.8%), with no differences between groups (early minor complications, 5.4%: 8.6% vs. 3.7% for SDD vs. NDD, p = 0.191; late major complications, 0.5%: 0% vs. 0.7%, p = 1; late minor complications, 3.4%: 2.9% vs. 3.7%, p = 1). There were five deaths (2.4%), none of which were procedure related. The SDD policy for CAP during this period would have saved €479.84 ± €248.09 per patient. (4) Conclusions: An SDD strategy was feasible and cost-saving and seemed to not increase periprocedural complications compared with an NDD strategy.
- Open Access
- 17 April 2026
- Published by BMJ in Open Heart
- Vol. 13 (1) , e004007
Epidemiology, economic burden and mortality of atrial fibrillation in a region with very high life expectancy: a contemporary, population-based analysis in Catalonia
Background: The high prevalence of atrial fibrillation (AF) and its association with cardiovascular (CV) outcomes represent a challenge for public health systems, particularly in ageing societies. Objective: The aim of this study was to conduct a thorough epidemiological analysis of AF in Catalonia, a region with high life expectancy, from prevalence and incidence to mortality and associated healthcare resource use. Methods: This retrospective population-based study used the database of the Catalan public health system, including 8 million people. AF prevalence, incidence and mortality were assessed from 2019 to 2023. Comorbidities and healthcare resource expenditure in prevalent AF cases were assessed for the year 2023. Analyses were adjusted for age, sex, income and comorbidities. Results: During the 5-year study period, the age-standardised prevalence of AF remained stable (2.5%), while incidence decreased, from 3.8‰ to 3.6‰. In 2023, the AF population had a median age of 77.6 years and had a high burden of comorbidities including heart failure (37.6%), obesity (33.8%) and coronary heart disease (26.7%). Low socioeconomic status was associated with higher AF prevalence. There was a modest association between AF and all-cause mortality (OR 1.25). The healthcare resource use associated with AF was estimated to account for 2% of the annual Catalan health budget. Conclusions: In Catalonia, AF prevalence has plateaued over the last 5 years and the incidence has decreased. Patients with AF have advanced mean age and a high burden of comorbidities. AF is associated with a modest increase in all-cause mortality, and its management represents 2% of the Catalan health budget.
- 17 April 2026
- Published by BMJ in Open Heart
- Vol. 13 (1) , e004007
Open AccessEpidemiology, economic burden and mortality of atrial fibrillation in a region with very high life expectancy: a contemporary, population-based analysis in Catalonia
Background: The high prevalence of atrial fibrillation (AF) and its association with cardiovascular (CV) outcomes represent a challenge for public health systems, particularly in ageing societies. Objective: The aim of this study was to conduct a thorough epidemiological analysis of AF in Catalonia, a region with high life expectancy, from prevalence and incidence to mortality and associated healthcare resource use. Methods: This retrospective population-based study used the database of the Catalan public health system, including 8 million people. AF prevalence, incidence and mortality were assessed from 2019 to 2023. Comorbidities and healthcare resource expenditure in prevalent AF cases were assessed for the year 2023. Analyses were adjusted for age, sex, income and comorbidities. Results: During the 5-year study period, the age-standardised prevalence of AF remained stable (2.5%), while incidence decreased, from 3.8‰ to 3.6‰. In 2023, the AF population had a median age of 77.6 years and had a high burden of comorbidities including heart failure (37.6%), obesity (33.8%) and coronary heart disease (26.7%). Low socioeconomic status was associated with higher AF prevalence. There was a modest association between AF and all-cause mortality (OR 1.25). The healthcare resource use associated with AF was estimated to account for 2% of the annual Catalan health budget. Conclusions: In Catalonia, AF prevalence has plateaued over the last 5 years and the incidence has decreased. Patients with AF have advanced mean age and a high burden of comorbidities. AF is associated with a modest increase in all-cause mortality, and its management represents 2% of the Catalan health budget.
- Open Access
- 12 April 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (5)
Targeting confluent areas of slow conduction and electrogram fragmentation for atrioventricular node re-entrant tachycardia ablation
Atrioventricular nodal re-entrant tachycardia (AVNRT) is the most common re-entrant supraventricular tachycardia. The Fractionation and WaveSpeed (WS) tools, available with the Omnipolar technology (OT) and the HD-Grid mapping catheter (Abbott Medical™, Abbott Park, IL) may help in the characterization of confluent areas (CAs) of electrogram fractionation and slow conduction in the inferoseptal isthmus,1 in the search for safer AVNRT ablation targets.
- 12 April 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (5)
Open AccessTargeting confluent areas of slow conduction and electrogram fragmentation for atrioventricular node re-entrant tachycardia ablation
Atrioventricular nodal re-entrant tachycardia (AVNRT) is the most common re-entrant supraventricular tachycardia. The Fractionation and WaveSpeed (WS) tools, available with the Omnipolar technology (OT) and the HD-Grid mapping catheter (Abbott Medical™, Abbott Park, IL) may help in the characterization of confluent areas (CAs) of electrogram fractionation and slow conduction in the inferoseptal isthmus,1 in the search for safer AVNRT ablation targets.
- 1 February 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (2) , e012473
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
BACKGROUND: Right ventricular apical pacing (RVAP) can produce left ventricle dysfunction. Conduction system pacing (CSP) has been used successfully to reverse left ventricle dysfunction in patients with left bundle branch block. To date, data about CSP prevention of left ventricle dysfunction in patients with preserved left ventricular ejection fraction (LVEF) are scarce and limited mostly to nonrandomized studies. Our aim is to demonstrate that CSP can preserve normal ventricular function compared with RVAP in the setting of a high burden of ventricular pacing. METHODS: Consecutive patients with a high-degree atrioventricular block and preserved or mildly deteriorated LVEF (>40%) were included in this prospective, randomized, parallel, controlled study, comparing conventional RVAP versus CSP. RESULTS: Seventy-five patients were randomized, with no differences between basal characteristics in both groups. The stimulated QRS duration was significantly longer in the RVAP group compared with the CSP group (160.4±18.1 versus 124.2±20.2 ms; p P P =0.04). Heart failure–related admissions were higher in the RVAP group (22.6% versus 5.1%; P =0.03). CONCLUSIONS: Conduction system stimulation prevents LVEF deterioration and heart failure–related admissions in patients with normal or mildly deteriorated LVEF requiring a high burden of ventricular pacing. These results are only short term and need to be confirmed by further larger studies. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT06026683.
- 1 February 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (2) , e012473
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
BACKGROUND: Right ventricular apical pacing (RVAP) can produce left ventricle dysfunction. Conduction system pacing (CSP) has been used successfully to reverse left ventricle dysfunction in patients with left bundle branch block. To date, data about CSP prevention of left ventricle dysfunction in patients with preserved left ventricular ejection fraction (LVEF) are scarce and limited mostly to nonrandomized studies. Our aim is to demonstrate that CSP can preserve normal ventricular function compared with RVAP in the setting of a high burden of ventricular pacing. METHODS: Consecutive patients with a high-degree atrioventricular block and preserved or mildly deteriorated LVEF (>40%) were included in this prospective, randomized, parallel, controlled study, comparing conventional RVAP versus CSP. RESULTS: Seventy-five patients were randomized, with no differences between basal characteristics in both groups. The stimulated QRS duration was significantly longer in the RVAP group compared with the CSP group (160.4±18.1 versus 124.2±20.2 ms; p P P =0.04). Heart failure–related admissions were higher in the RVAP group (22.6% versus 5.1%; P =0.03). CONCLUSIONS: Conduction system stimulation prevents LVEF deterioration and heart failure–related admissions in patients with normal or mildly deteriorated LVEF requiring a high burden of ventricular pacing. These results are only short term and need to be confirmed by further larger studies. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT06026683.